SRI SPV 1026 a Series of CGF2026 LLC has announced the successful completion of a private offering, raising a total of $94,000. This development is significant as it underscores the company's ability to attract investment in a competitive market.
The company, SRI SPV 1026 a Series of CGF2026 LLC, operates as a pooled investment fund, specifically in the venture capital sector. Incorporated in Delaware, it has recently filed its offering details with the SEC on October 29, 2026.
According to the filing, the total offering amount was $94,000, which has been fully sold. The proceeds from this offering will be utilized to cover organizational and operational expenses, with $4,000 earmarked for this purpose. The filing states, "This amount represents a cost to cover fund organizational and operating expenses." The offering was conducted under Rule 506(b) of the SEC, which provides a safe harbor for private offerings.
This successful fundraising effort may affect various stakeholders, including the 12 investors who participated in the offering. Notably, the filing indicates that there were no non-accredited investors involved in this round of funding.
As for what lies ahead, the filing does not specify any further actions or upcoming filings related to this offering.
Company Overview
SRI SPV 1026 a Series of CGF2026 LLC is a limited liability company incorporated in Delaware in 2026. The company operates as a pooled investment fund, specifically focusing on the venture capital sector. Its business address is located at 2093 Philadelphia Pike, Suite 5885, Claymont, Delaware, 19703.
As per the SEC filing, the company does not disclose its revenue range, stating a decline to disclose, which may indicate a nascent stage of operations or strategic privacy regarding financial performance.
Management and Leadership
The filing identifies Jason Troutner as the Executive Officer of the company, providing a point of contact for stakeholders. His address is listed as 405 Morris Avenue, Providence, Rhode Island, 02906.
Offering Details and Compliance
The offering was conducted under Rule 506(b) of the SEC, which allows for the sale of securities to accredited investors without the need for registration. The filing confirms that there were no non-accredited investors involved in this offering, ensuring compliance with SEC regulations.
"This amount represents a cost to cover fund organizational and operating expenses."
The total offering amount was fully sold, with no remaining securities available for purchase. The company has indicated that no sales commissions or finders' fees were paid in connection with this offering, reflecting a straightforward fundraising approach.
Future Considerations
The filing does not provide any information regarding future offerings, strategic plans, or potential expansions for SRI SPV 1026 a Series of CGF2026 LLC. Investors may look forward to updates from the company as it continues to develop its operations in the venture capital space.
Read Next
Mirum Pharmaceuticals reports stock sale by former officer
Basswood Financial Fund sells shares of Regional Management Corp.
Basswood Financial Fund Files to Sell Shares in Regional Management
HCA Healthcare Officer Jon M. Foster Files to Sell Shares
Regional Management Corp. Sees Shareholder Stock Sale
Wampler Kira Scherer Reports Stock Transactions for Doximity










